journal article·2025-02-19Open access

Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming

Han Gao, Ruoyu Cheng, Inês Cardoso, Maria Lobita, Idaira Pacheco-Fernández, Raquel Bártolo, Lígia R. Rodrigues, Jouni Hirvonen, Hélder A. Santos

Nano Letters· Volume 25· Issue 7

Abstract

High Resolution Image Download MS PowerPoint Slide The immune system safeguards as primary defense by recognizing nanomaterials and maintaining homeostasis, gaining a deeper understanding of these interactions may change the treating paradigm of immunotherapy. Here, we adopted copper as the principal component of nanoparticles (NPs), given its features of coordination with different benezenecarboxylate ligands to form metal–organic frameworks and complexes with distinct morphologies. As a result, four types of shape-tunable copper-coordinated NPs (CuCNPs) are developed: cuboctahedron, needle, octahedron, and plate NPs. Biocompatibility of CuCNPs varies across different cell lines (RAW264.7, THP-1, HEK 293 and HeLa) in a shape-dependent manner, with needle-shaped CuCNPs showing pronounced cytotoxicity (IC50:104.3 μg mL –1 at 24 h). Among different shapes, a notable increase of 8.47% in the CD206 + subpopulations is observed in needle-shaped CuCNPs, followed by 77% enhancement at 48 h. Overall, this study underscores the shape-dependent immune-regulatory effects of CuCNPs and sheds light on the rational design of nanoscale metal complexes for potential immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy

University of Helsinki

CEB - Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal

Funding

Universitair Medisch Centrum Groningen · H2020 Marie Sklodowska-Curie Actions · China Scholarship Council

References (61)

Show source-provided references
1. 10.1038/s44222-022-00016-210.1038/s44222-022-00016-2 ↗
2. 10.1038/s44222-023-00047-310.1038/s44222-023-00047-3 ↗
3. 10.1002/adma.20200180810.1002/adma.202001808 ↗
4. 10.1039/D3QM00603D10.1039/D3QM00603D ↗
5. 10.1002/anie.20120841410.1002/anie.201208414 ↗
6. 10.1021/cr300282410.1021/cr3002824 ↗
7. 10.1016/j.trechm.2021.03.00610.1016/j.trechm.2021.03.006 ↗
8. 10.1039/b905798f10.1039/b905798f ↗
9. 10.1002/adhm.20230207410.1002/adhm.202302074 ↗
10. 10.1021/acschembio.5b0051310.1021/acschembio.5b00513 ↗
11. 10.3389/fchem.2020.62983510.3389/fchem.2020.629835 ↗
12. 10.1039/C7MT00156H10.1039/C7MT00156H ↗
13. 10.3892/mmr.2016.602210.3892/mmr.2016.6022 ↗
14. 10.1016/j.jcis.2021.02.03710.1016/j.jcis.2021.02.037 ↗
15. 10.1021/acs.nanolett.8b0475710.1021/acs.nanolett.8b04757 ↗
16. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
17. 10.1186/s12951-022-01343-710.1186/s12951-022-01343-7 ↗
18. 10.1039/D2RA03027F10.1039/D2RA03027F ↗
19. 10.1016/j.jconrel.2015.09.06910.1016/j.jconrel.2015.09.069 ↗
20. 10.1038/s41598-017-04229-z10.1038/s41598-017-04229-z ↗
21. 10.1016/j.chemosphere.2024.14282610.1016/j.chemosphere.2024.142826 ↗
22. 10.1016/j.ccr.2020.21354210.1016/j.ccr.2020.213542 ↗
23. 10.1021/cr200304e10.1021/cr200304e ↗
24. 10.1002/ejic.20080122410.1002/ejic.200801224 ↗
25. 10.1021/ja204233q10.1021/ja204233q ↗
26. 10.1021/ja203799610.1021/ja2037996 ↗
27. 10.1016/j.micromeso.2022.11193810.1016/j.micromeso.2022.111938 ↗
28. 10.1039/D0SC01356K10.1039/D0SC01356K ↗
29. 10.1107/S010827010701985310.1107/S0108270107019853 ↗
30. 10.1016/j.jconrel.2012.12.01310.1016/j.jconrel.2012.12.013 ↗
31. 10.1088/1748-605X/abe5fa10.1088/1748-605X/abe5fa ↗
32. 10.1002/jbm.a.3541510.1002/jbm.a.35415 ↗
33. 10.1016/j.gene.2015.05.06510.1016/j.gene.2015.05.065 ↗
34. 10.1002/adhm.20200024810.1002/adhm.202000248 ↗
35. 10.3389/fimmu.2021.70000910.3389/fimmu.2021.700009 ↗
36. 10.4049/jimmunol.164.5.269210.4049/jimmunol.164.5.2692 ↗
37. 10.3390/ijms2404422010.3390/ijms24044220 ↗
38. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
39. 10.1038/cdd.2012.8210.1038/cdd.2012.82 ↗
40. 10.1016/j.cimid.2009.07.00110.1016/j.cimid.2009.07.001 ↗
41. 10.1038/s41392-021-00658-510.1038/s41392-021-00658-5 ↗
42. 10.1186/1742-2094-11-2310.1186/1742-2094-11-23 ↗
43. 10.3892/ijo.27.1.12110.3892/ijo.27.1.121 ↗
44. 10.3389/fimmu.2019.0146210.3389/fimmu.2019.01462 ↗
45. 10.3389/fimmu.2014.0049110.3389/fimmu.2014.00491 ↗
46. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
47. 10.1002/smll.20220029110.1002/smll.202200291 ↗
48. 10.1021/acsnano.0c0891310.1021/acsnano.0c08913 ↗
49. 10.1038/s41584-024-01084-x10.1038/s41584-024-01084-x ↗
50. 10.1016/j.ccr.2022.21461210.1016/j.ccr.2022.214612 ↗
51. 10.1021/acsanm.8b0128310.1021/acsanm.8b01283 ↗
52. 10.1155/2021/995444310.1155/2021/9954443 ↗
53. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
54. 10.1021/nn200365a10.1021/nn200365a ↗
55. 10.1016/j.ejphar.2020.17309010.1016/j.ejphar.2020.173090 ↗
56. 10.1038/s41392-023-01452-110.1038/s41392-023-01452-1 ↗
57. 10.3389/fimmu.2017.0012010.3389/fimmu.2017.00120 ↗
58. 10.1016/j.bbiosy.2023.10007310.1016/j.bbiosy.2023.100073 ↗
59. 10.3390/nano1111299110.3390/nano11112991 ↗
60. 10.1182/blood-2010-08-26589210.1182/blood-2010-08-265892 ↗
61. 10.1038/nri100110.1038/nri1001 ↗